Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on the Safety and Effectiveness of ProTrans for Treating Type 1 Diabetes in Children and Adolescents
SwedenStudy on the Safety and Effectiveness of Pegcetacoplan for Patients with Post-Transplant Recurrence of C3 Glomerulopathy or Immune Complex Membranoproliferative Nephritis
AustriaStudy on the Effectiveness and Safety of Barzolvolimab for Patients with Chronic Inducible Urticaria
BulgariaStudy on the Safety and Efficacy of Empasiprubart for Adults with Dermatomyositis
GreeceStudy comparing dexamethasone versus immunoglobulin plus prednisone for adults with immune thrombocytopenia (ITP) who have moderate to severe bleeding
FranceStudy on the Safety of Allogeneic Mesenchymal Stromal Cells for Patients with Chronic Lung Transplant Rejection
SpainStudy on the Effects of Hyperbaric Oxygen Therapy for Patients with Moderate-to-Severe Ulcerative Colitis
The NetherlandsStudy on the Long-Term Safety of STAR-0215 for Adults with Hereditary Angioedema
BulgariaStudy on Rezpegaldesleukin for Treating Severe Alopecia Areata in Adults
PolandStudy on the Effects of Sonelokimab for Patients with Active Axial Spondyloarthritis
GermanyStudy on the Effectiveness of Isatuximab, Pomalidomide, and Dexamethasone for Patients with AL Amyloidosis Not Responding Well to Previous Treatments
FranceStudy on Canakinumab for Patients with PAPA Syndrome
ItalyThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
